Medifast (NYSE:MED) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.52) by 63.46 percent. This is a 171.43 percent decrease over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $76.044 million which beat the analyst consensus estimate of $69.200 million by 9.89 percent. This is a 34.29 percent decrease over sales of $115.728 million the same period last year.